Intech Biopharm Corporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 3.563 million compared to TWD 4.491 million a year ago. Operating loss was TWD 63.359 million compared to TWD 77.250 million a year ago. Net loss was TWD 65.573 million compared to TWD 80.941 million a year ago. Basic loss per share was TWD 0.65 compared to TWD 1.01 a year ago. For the nine months, sales was TWD 15.330 million compared to TWD 12.807 million a year ago. Operating loss was TWD 177.934 million compared to TWD 219.602 million a year ago. Net loss was TWD 185.168 million compared to TWD 226.790 million a year ago. Basic loss per share was TWD 1.85 compared to TWD 2.83 a year ago.